N-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide

C150H187N35O7 — CID 159924054

IUPACN-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide
SMILESCCn1cc(-c2cc(NC(=O)CCCN3CCCCC3)n[nH]2)c2ccccc21.CCn1ccc2cc(-c3cc(NC(=O)CCCN4CCCCC4)n[nH]3)ccc21.CCn1ccc2ccc(-c3cc(NC(=O)CCCN4CCCCC4)n[nH]3)cc21.Cc1ccc2cc(-c3cc(NC(=O)CCCN4CCCC4)n[nH]3)ccc2n1.Cc1ccc2cc(-c3cc(NC(=O)CCCN4CCCCC4)n[nH]3)ccc2n1.O=C(CCCN1CCCC1)Nc1cc(-c2cnc3ccccc3c2)[nH]n1.O=C(CCCN1CCCCC1)Nc1cc(-c2cnc3ccccc3c2)[nH]n1
InChIInChI=1S/C22H27N5O.3C22H29N5O.2C21H25N5O.C20H23N5O/c1-16-7-8-17-14-18(9-10-19(17)23-16)20-15-21(26-25-20)24-22(28)6-5-13-27-11-3-2-4-12-27;1-2-27-16-18(17-9-4-5-10-20(17)27)19-15-21(25-24-19)23-22(28)11-8-14-26-12-6-3-7-13-26;1-2-27-14-10-18-15-17(8-9-20(18)27)19-16-21(25-24-19)23-22(28)7-6-13-26-11-4-3-5-12-26;1-2-27-14-10-17-8-9-18(15-20(17)27)19-16-21(25-24-19)23-22(28)7-6-13-26-11-4-3-5-12-26;1-15-6-7-16-13-17(8-9-18(16)22-15)19-14-20(25-24-19)23-21(27)5-4-12-26-10-2-3-11-26;27-21(9-6-12-26-10-4-1-5-11-26)23-20-14-19(24-25-20)17-13-16-7-2-3-8-18(16)22-15-17;26-20(8-5-11-25-9-3-4-10-25)22-19-13-18(23-24-19)16-12-15-6-1-2-7-17(15)21-14-16/h7-10,14-15H,2-6,11-13H2,1H3,(H2,24,25,26,28);4-5,9-10,15-16H,2-3,6-8,11-14H2,1H3,(H2,23,24,25,28);2*8-10,14-16H,2-7,11-13H2,1H3,(H2,23,24,25,28);6-9,13-14H,2-5,10-12H2,1H3,(H2,23,24,25,27);2-3,7-8,13-15H,1,4-6,9-12H2,(H2,23,24,25,27);1-2,6-7,12-14H,3-5,8-11H2,(H2,22,23,24,26)
InChIKeyNYTXWBYQGFOYSG-UHFFFAOYSA-N
MW2592.38 g/mol
LogP27.92
Rot. Bonds45

About N-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide

N-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide (PubChem CID 159924054) has the molecular formula C150H187N35O7 and a molecular weight of 2592.38 g/mol. Its IUPAC name is N-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide.

Molecular Properties

Compound NameN-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide
PubChem CID159924054
Molecular FormulaC150H187N35O7
Molecular Weight2592.38 g/mol
Exact Mass2590.54
IUPAC NameN-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide
SMILESCCn1cc(-c2cc(NC(=O)CCCN3CCCCC3)n[nH]2)c2ccccc21.CCn1ccc2cc(-c3cc(NC(=O)CCCN4CCCCC4)n[nH]3)ccc21.CCn1ccc2ccc(-c3cc(NC(=O)CCCN4CCCCC4)n[nH]3)cc21.Cc1ccc2cc(-c3cc(NC(=O)CCCN4CCCC4)n[nH]3)ccc2n1.Cc1ccc2cc(-c3cc(NC(=O)CCCN4CCCCC4)n[nH]3)ccc2n1.O=C(CCCN1CCCC1)Nc1cc(-c2cnc3ccccc3c2)[nH]n1.O=C(CCCN1CCCCC1)Nc1cc(-c2cnc3ccccc3c2)[nH]n1
InChIInChI=1S/C22H27N5O.3C22H29N5O.2C21H25N5O.C20H23N5O/c1-16-7-8-17-14-18(9-10-19(17)23-16)20-15-21(26-25-20)24-22(28)6-5-13-27-11-3-2-4-12-27;1-2-27-16-18(17-9-4-5-10-20(17)27)19-15-21(25-24-19)23-22(28)11-8-14-26-12-6-3-7-13-26;1-2-27-14-10-18-15-17(8-9-20(18)27)19-16-21(25-24-19)23-22(28)7-6-13-26-11-4-3-5-12-26;1-2-27-14-10-17-8-9-18(15-20(17)27)19-16-21(25-24-19)23-22(28)7-6-13-26-11-4-3-5-12-26;1-15-6-7-16-13-17(8-9-18(16)22-15)19-14-20(25-24-19)23-21(27)5-4-12-26-10-2-3-11-26;27-21(9-6-12-26-10-4-1-5-11-26)23-20-14-19(24-25-20)17-13-16-7-2-3-8-18(16)22-15-17;26-20(8-5-11-25-9-3-4-10-25)22-19-13-18(23-24-19)16-12-15-6-1-2-7-17(15)21-14-16/h7-10,14-15H,2-6,11-13H2,1H3,(H2,24,25,26,28);4-5,9-10,15-16H,2-3,6-8,11-14H2,1H3,(H2,23,24,25,28);2*8-10,14-16H,2-7,11-13H2,1H3,(H2,23,24,25,28);6-9,13-14H,2-5,10-12H2,1H3,(H2,23,24,25,27);2-3,7-8,13-15H,1,4-6,9-12H2,(H2,23,24,25,27);1-2,6-7,12-14H,3-5,8-11H2,(H2,22,23,24,26)
InChIKeyNYTXWBYQGFOYSG-UHFFFAOYSA-N
XLogP27.92
TPSA493.49 Ų
H-Bond Donors14
H-Bond Acceptors28
Rotatable Bonds45
Heavy Atoms192
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002592.38
LogP ≤ 527.92
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1028

Analyze N-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide?
The IUPAC name of N-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide (CID 159924054) is N-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide.
What is the SMILES notation for N-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide?
The canonical SMILES for N-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide is CCn1cc(-c2cc(NC(=O)CCCN3CCCCC3)n[nH]2)c2ccccc21.CCn1ccc2cc(-c3cc(NC(=O)CCCN4CCCCC4)n[nH]3)ccc21.CCn1ccc2ccc(-c3cc(NC(=O)CCCN4CCCCC4)n[nH]3)cc21.Cc1ccc2cc(-c3cc(NC(=O)CCCN4CCCC4)n[nH]3)ccc2n1.Cc1ccc2cc(-c3cc(NC(=O)CCCN4CCCCC4)n[nH]3)ccc2n1.O=C(CCCN1CCCC1)Nc1cc(-c2cnc3ccccc3c2)[nH]n1.O=C(CCCN1CCCCC1)Nc1cc(-c2cnc3ccccc3c2)[nH]n1.
What is the InChIKey of N-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide?
The InChIKey is NYTXWBYQGFOYSG-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H27N5O.3C22H29N5O.2C21H25N5O.C20H23N5O/c1-16-7-8-17-14-18(9-10-19(17)23-16)20-15-21(26-25-20)24-22(28)6-5-13-27-11-3-2-4-12-27;1-2-27-16-18(17-9-4-5-10-20(17)27)19-15-21(25-24-19)23-22(28)11-8-14-26-12-6-3-7-13-26;1-2-27-14-10-18-15-17(8-9-20(18)27)19-16-21(25-24-19)23-22(28)7-6-13-26-11-4-3-5-12-26;1-2-27-14-10-17-8-9-18(15-20(17)27)19-16-21(25-24-19)23-22(28)7-6-13-26-11-4-3-5-12-26;1-15-6-7-16-13-17(8-9-18(16)22-15)19-14-20(25-24-19)23-21(27)5-4-12-26-10-2-3-11-26;27-21(9-6-12-26-10-4-1-5-11-26)23-20-14-19(24-25-20)17-13-16-7-2-3-8-18(16)22-15-17;26-20(8-5-11-25-9-3-4-10-25)22-19-13-18(23-24-19)16-12-15-6-1-2-7-17(15)21-14-16/h7-10,14-15H,2-6,11-13H2,1H3,(H2,24,25,26,28);4-5,9-10,15-16H,2-3,6-8,11-14H2,1H3,(H2,23,24,25,28);2*8-10,14-16H,2-7,11-13H2,1H3,(H2,23,24,25,28);6-9,13-14H,2-5,10-12H2,1H3,(H2,23,24,25,27);2-3,7-8,13-15H,1,4-6,9-12H2,(H2,23,24,25,27);1-2,6-7,12-14H,3-5,8-11H2,(H2,22,23,24,26).
What are the key properties of N-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide?
N-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide has a molecular weight of 2592.38 g/mol, XLogP of 27.92, 45 rotatable bonds, 14 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-(1-ethylindol-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-5-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(1-ethylindol-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutanamide;N-[5-(2-methylquinolin-6-yl)-1H-pyrazol-3-yl]-4-pyrrolidin-1-ylbutanamide;4-piperidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide;4-pyrrolidin-1-yl-N-(5-quinolin-3-yl-1H-pyrazol-3-yl)butanamide is sourced from PubChem (CID 159924054), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).